Literature DB >> 1527416

Clinical features of sporadic Yersinia enterocolitica infections in Norway.

S M Ostroff1, G Kapperud, J Lassen, S Aasen, R V Tauxe.   

Abstract

During October 1988 through January 1990, a study of sporadic Yersinia enterocolitica infections was done in the Oslo region to assess the clinical impact and risk factors for this disease. Sixty-seven case-patients (mean age, 23.4 years) and 132 population-based age- and sex-matched controls were enrolled. Among patients who were well when interviewed, illness lasted a mean of 20 days, but 10% of the others remained symptomatic a year later. Bloody diarrhea occurred only in persons less than 18 years old (P = .002); joint pain was more common in adults (P = .001). Prolonged carriage was found in 47% of patients after resolution of symptoms. Patients were less likely to shed the organism after antimicrobial treatment (relative risk, 0.3; P = .003). Case-patients were more likely than controls to have antecedent enteric illness (odds ratio, 8.2; P less than .001). Y. enterocolitica infection in Norway is notable for its severity and chronicity. Postsymptomatic shedding, which occurs commonly, may be reduced by antimicrobial treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1527416     DOI: 10.1093/infdis/166.4.812

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Association between clinical presentation, biogroups and virulence attributes of Yersinia enterocolitica strains in human diarrhoeal disease.

Authors:  A P Burnens; A Frey; J Nicolet
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

2.  Yersinia enterocolitica sepsis in a 3-week-old child.

Authors:  E C Thompson
Journal:  J Natl Med Assoc       Date:  1994-10       Impact factor: 1.798

3.  Probable transmission of Yersinia enterocolitica from a pet dog with diarrhoea to a 1-year-old infant.

Authors:  D J Hetem; M Pekelharing; S F T Thijsen
Journal:  BMJ Case Rep       Date:  2013-08-16

Review 4.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

5.  Symptoms and sources of Yersinia enterocolitica-infection: a case-control study.

Authors:  Elisa Huovinen; Leila M Sihvonen; Mikko J Virtanen; Kaisa Haukka; Anja Siitonen; Markku Kuusi
Journal:  BMC Infect Dis       Date:  2010-05-20       Impact factor: 3.090

6.  Prevalence of antibodies to Yersinia enterocolitica O:3 among Norwegian military recruits: association with risk factors and clinical manifestations.

Authors:  A Saebø; G Kapperud; J Lassen; J Waage
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

7.  Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study.

Authors:  S M Ostroff; G Kapperud; L C Hutwagner; T Nesbakken; N H Bean; J Lassen; R V Tauxe
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

8.  Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden.

Authors:  Kristian Sundström
Journal:  Appl Health Econ Health Policy       Date:  2018-04       Impact factor: 2.561

9.  Chronic Lyme Disease and Co-infections: Differential Diagnosis.

Authors:  Walter Berghoff
Journal:  Open Neurol J       Date:  2012-12-28

10.  Clinical aspects and self-reported symptoms of sequelae of Yersinia enterocolitica infections in a population-based study, Germany 2009-2010.

Authors:  Bettina M Rosner; Dirk Werber; Michael Höhle; Klaus Stark
Journal:  BMC Infect Dis       Date:  2013-05-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.